Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expanding PrEP Options Among Young MSM, Transgender and Non-binary Persons in Brazil: Incorporating Twice-yearly Lenacapavir for HIV Prevention - The ImPrEP LEN Brasil Study

NCT07497594 is registered in ClinicalTrials.gov with Oswaldo Cruz Foundation as lead sponsor.

NCT NCT07497594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07497594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expanding PrEP Options Among Young MSM, Transgender and Non-binary Persons in Brazil: Incorporating Twice-yearly Lenacapavir for HIV Prevention - The ImPrEP LEN Brasil Study
Lead sponsor
Oswaldo Cruz Foundation
Phase
Not applicable
Overall status
Recruiting
Start date
February 3, 2026
Completion date
September 30, 2029
Enrollment
1,500 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

contact with or exposure to human immunodeficiency virus